Aibin Liang
- Genetics top 5%
- Virus-based gene therapy research 10
- Oncology top 5%
- CAR-T cell therapy research 44
- Urology top 5%
- Geriatrics and Gerontology top 10%
- Cancer Research top 10%
-
- Acute Myeloid Leukemia Research 19
-
- Lymphoma Diagnosis and Treatment 19
-
- Integrated Circuits and Semiconductor Failure Analysis 9
- Advancements in Semiconductor Devices and Circuit Design 7
-
- Immune Cell Function and Interaction 8
-
- Acute Lymphoblastic Leukemia research 7
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Aibin Liang
104 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 111
- Genetics 247
- Oncology 498
- Urology 87
- Geriatrics and Gerontology 49
- Cancer Research 182
Countries citing papers authored by Aibin Liang
This map shows the geographic impact of Aibin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aibin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aibin Liang more than expected).
Fields of papers citing papers by Aibin Liang
This network shows the impact of papers produced by Aibin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aibin Liang. The network helps show where Aibin Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aibin Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 14 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 12 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 5 | |
| 19 | 2016 | 10 | |
| 20 | 2013 | 5 |
About Aibin Liang
Aibin Liang is a scholar working on Hematology, Oncology and Genetics, having authored 117 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (44 papers), Acute Myeloid Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (19 papers), Virus-based gene therapy research (10 papers), Integrated Circuits and Semiconductor Failure Analysis (9 papers), Immune Cell Function and Interaction (8 papers), Advancements in Semiconductor Devices and Circuit Design (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). The work is most often cited by research in Genetics (247 citations), Oncology (498 citations) and Urology (87 citations). Aibin Liang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Wenjun Zhang, Yu Fang, Yao Sun, Junjun Liu, Jianhua Yang, Beizhan Jiang, Guo‐Tong Xu, Bing Xiu, Ping Li and Wenbin Qian. Their work appears in journals such as Blood, Frontiers in Immunology, Oncology Reports, Journal of Experimental & Clinical Cancer Research and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.